Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics

Alcohol and Alcoholism

Volumn 33, Issue 2, 1998, Pages 151-156

  Angelone, Sara M ^a   Bellini, Laura ^a   Di Bella, Daniela ^a   Catalano, Marco ^a  

^a Centro di Alcologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CITALOPRAM; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RELAPSE;

EID: 0031949611     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.alcalc.a008371     Document Type: Article

References (31)

1. Alietti, M., Catalano, M., Tosi, M. and Vittadini, M. (1993) Valutazione dell'efficacia di un inibitore del re-uptake di 5-HT (fluvoxamina) sul controllo delle ricadute in alcolisti primari. In L'Alcologia Verso il 2000: Progressi e Formazione, Carrieri, F., Albano, O., Marzi, B. eds, pp. 133-135. CIC Edizioni Intemazionali, Rome.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association. Washington, D.C.
3. Bailly, D., Vignau, J., Lauth, B. et al. (1990) Platelet serotonin decrease in alcoholic patients. Acta Psychiatrica Scandinavica 81, 68-72.
4. Balldin, J., Berggren, U., Engel, J., Eriksson, M., Hard, E. and Soderpalm, B. (1994) Effect of citalopram on alcohol intake in heavy drinkers. Alcoholism: Clinical and Experimental Research 18, 1133-1136.
5. Batel, P. (1995) The treatment of alcoholism in France. Drug and Alcohol Dependence 39 (Suppl. 1), 15-21.
6. Borg, S., Kvande, H., Liljeberg, P., Mossberg, D. and Valverius, P. (1985) 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol 2, 415-418.
7. Brosen, K. (1993) The pharmacogenetics of the selective serotonin reuptake inhibitors. Clinical Investigator 71, 1002-1009.
8. Buydens-Branchey, L., Branchey, M. H., Noumair, D. and Lieber, C. S. (1989) Age of alcoholism onset: II. Relationship to susceptibility to serotonin precursor availability. Archives of General Psychiatry 46, 231-236.
9. Finley, P. R. (1994) Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Annals of Pharmacotherapy 28, 1359-1369.
10. Fredricson Overo, K. (1987) The role of pharmacokinetics in the development of new drugs: an illustration by studies on citalopram. Thesis, Copenhagen.
11. Gorelick, D. A. and Paredes, A. (1992) Effect of fluoxetine on alcohol consumption in male alcoholics. Alcoholism: Clinical and Experimental Research 16, 261-265.
12. Jusko, W. J. and Gretch, M. (1976) Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metabolism Review 5, 43-140.
13. Kranzler, H. R., Del Boca, F., Korner, P. and Brown, J. (1993) Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism. Journal of Substance Abuse Treatment 10, 283-287.
14. Lane, R., Baldwin, D. and Preskorn, S. (1995) The SSRIs: advantages, disadvantages and differences. Journal of Psychopharmacology 9 (Suppl. 2), 163-178.
15. Le Marquand, D., Pihl, R. O. and Benkelfat, C. (1994a) Serotonin and alcohol intake, abuse and dependence: clinical evidence. Biological Psychiatry 36, 326-337.
16. Le Marquand, D., Pihl, R. O. and Benkelfat, C. (1994b) Serotonin and alcohol intake, abuse and dependence: findings of animal studies. Biolocal Psychiatry 36, 395-421.
17. Movalli, M. G., Madeddu, F., Fossati, A. and Maffei, C. (1996) Personality Disorders (DSM-III-R-DSM-IV): prevalence in alcoholics and influence on drop out from treatment. Alcologia 8, 47-52.
18. Naranjo, C. A. and Kadlec, K. E. (1991) An evaluation of the clinical effects of serotonin uptake inhibitors in alcoholics. Biological Psychiatry 29, 510S.
19. Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley, D. V., Kadlek, K. and Sykora, K. (1987) The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clinical Pharmacology and Therapeutics 41, 266-274.
20. Naranjo, C. A., Poulos, C. X., Bremner, K. E. and Lanctot, K. L. (1992) Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clinical Pharmacology and Therapeutics 51, 729-739.
21. Naranjo, C. A., Poulos, C. X., Bremner, K. E. and Lanctot, K. L. (1994) Fluoxetine attenuates alcohol intake and desire to drink. International Clinical Psychopharmacology 9, 163-172.
22. Naranjo, C. A., Bremner, K. E. and Lanctot, K. L. (1995) Effects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems. Addiction 90, 87-99.
23. Pandey, S. C., Davis, J. M. and Pandey, G. N. (1995) Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates. Journal of Psychiatry and Neurosciences 20, 215-225.
24. Selzer, M. L. (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. American Journal of Psychiatry 127, 1653-1658.
25. SPSS Inc. (1988) SPSS-X User's Guide, 3rd edn. McGraw-Hill, New York.
26. Stark, M. J. (1992) Dropping out of substance abuse treatment: a clinically oriented review. Clinical Psychology Review 12, 93-116.
27. Statistica for Windows (1993) Release 4.5, Statsoft. Inc., Tulsa, OK, USA.
28. Tabakoff, B. and Hoffman, P. L. (1991) Neurochemical effects of alcohol. In Clinical Textbook of Addictive Disorders, Frances R. J., Miller S. I., eds, pp. 501-525. Guilford Press, New York.
29. Thomas, R. (1991) Fluvoxamine and alcoholism. International Clinical Psychophannacology 6 (Suppl. 3), 85-92.
30. Tiffany, S. T. (1990) A cognitive model of drug urges and drug-use behaviors: role of automatic and nonautomatic processes. Psychological Review 97, 147-168.
31. Zanardi, R., Franchini, L., Gasperini, M., Perez, J. and Smeraldi, E. (1996) A double blind controlled trial of sertraline vs paroxetine in the treatment of delusional depression. American Journal of Psychiatry 153, 1631-1633.